TrialJournal of the National Cancer Institute2012

CYP2D6 genotype and tamoxifen response in postmenopausal women with endocrine-responsive breast cancer: the breast international group 1-98 trial.

Meredith M Regan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.